我国药品行政保护研究  

Pharmaceutical Administrative Protection in China

作　　者：杨莉[1] 李野[1] 杨立夫[2] 

机构地区：[1]沈阳药科大学工商管理学院,沈阳市110016 [2]沈阳市奉天医院药剂科,沈阳市110016

出　　处：《中国药房》2008年第19期1446-1448,共3页China Pharmacy

摘　　要：目的:为我国制药企业更好地理解和合理利用药品行政保护提供参考。方法:从我国药品行政保护的产生、发展和具体规定入手来界定药品行政保护的实质和涵义,并对其作用、存在的弊端及未来的发展方向进行分析。结果与结论:药品行政保护是我国药品知识产权保护体系的重要组成部分,在保护药品知识产权、促进我国制药业发展方面起到了重要作用,但也存在一些弊端,有待继续完善。OBJECTIVE： To provide reference for Chinese pharmaceutical manufacturing enterprises to better understand and reasonable utilize the pharmaceutical administrative protection. METHODS： The essence and connotation of pharmaceutical administrative protection were defined by analyzing its origin, development and the regulations; and its role, shortcomings and future development were analyzed. RESULTS ＆ CONCLUSIONS： Pharmaceutical administrative protection is a key part of pharmaceutical intellectual property protection system and plays a very important role in protecting pharmaceutical intellectual property and promoting the development of pharmaceutical industry. Yet it remains to be further improved in view of its shortcomings.

关 键 词：药品行政保护 研究 中国 

分 类 号：R951[医药卫生—药学]